EDITORIAL ARTICLE
Kidney involvement in antiphospholipid syndrome – current diagnostic and management problems
Online publication date: 2017-10-28
Reumatologia 2017;55(5):213-214
REFERENCES (15)
1.
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2.
Gerosa M, Rovelli F. Non-classification criteria w Antiphospholid antibody syndrome – from bench to bedside. In: Antiphospholid antibody syndrome – from bench to bedside, Meroni PL (ed.). Springer, Heidelberg, New York, Dordrecht, London 2015: 61-74.
3.
Abreu MM, Danowski A, Wahl DG, et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev 2015; 14: 401-414.
4.
Gracia-Tello B, Isenberg D. Kidney disease in primary antiphospholipid antibody syndrome. Rheumatology 2017; 56: 1069-1080.
5.
Bienaime F, Legendre Ch, Terzi F, et al. Antiphospholipid syndrome and kidney disease. Kidney Int 2017; 91: 34-44.
6.
Sciascia S, Baldovino S, Schreiber K, et al. Antiphospholipid syndrome and the Kidney. Semin Nephrol 2015; 35: 478-486.
7.
Tektonidou MG. Identification and treatment of APS renal involvement. Lupus 2014; 23: 1276-1278.
8.
Alchi B, Griffiths M, Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 2010; 25: 3147-3154.
9.
Majdan M. The kidney and antiphospholipid syndrome. Pol Arch Med Wewn 2007; 117 (suppl 1): 55-58.
10.
Majdan M. Antiphospholipid syndrome and kidney diseases. Pol Merkur Lek 2010; 28: 341-344.
11.
Ünlu O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016; 3: 75-84.
12.
Gerhardsson J, Sundelin B, Zickert A, et al. Histological antiphospholipid – associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up. Arthritis Res Ther 2015; 17: 109.
13.
Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 2015; 11: 586-596.
14.
Choi JY, Jung JH, Sung S, et al. Living donor renal transplantation with antiphospholipid syndrome. Medicine 2016; 95: 46-50.
15.
Geethakumari PR, Mille P, Gulati, Nagalla S. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patients with antiphospholipid antibody syndrome. Transfus Appher Sci 2017; 56: 400-403.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
